Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of Medicine’s Pediatric Hematology, Oncology and BMT. This position is involved in studies aimed at understanding the role of transcriptional gene regulation in hematopoietic stem cells and mutations found in
-
. Our group works on basic science projects on gene regulation in blood stem cells (e.g. Frömel et al., Cell 2025 ), and more translational projects in the context of acute myeloid leukemia (AML) and pre
-
https://www.sbme.ubc.ca/ . The Stem Cell Bioengineering Lab (https://www.stemcellbioengineering.ca ), located in UBC’s School of Biomedical Engineering, develops integrated computational and experimental
-
Surgeons and New York-Presbyterian Hospital are recruiting for a full-time academic pediatric faculty member in the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at the Instructor
-
Postgraduate Research Assistant, you will be directly involved in the day-to-day culture and maintenance of induced pluripotent stem cells (iPSC), differentiation of iPSCs into cardiomyocytes in 2D and 3D
-
Fondazione Banca degli Occhi del Veneto (The Veneto Eye Bank Foundation) | Italy | about 1 month ago
cell therapies and biomaterials, laying the groundwork for future cures to restore eyesight. As one of the doctoral candidates in STEM-CORE, you will receive comprehensive training to become a leading
-
Description Job Summary: Under the direction of the PI and senior scientists, the Laboratory Technician will be responsible for the daily maintenance of human pluripotent stem cells and 3D cerebral organoids
-
(LKCMedicine) is a collaborative, forwarding-thinking, and innovative cell biology research laboratory. The lab aims to conduct impactful and creative cancer and stem cell research by leveraging 3D cell models
-
admitted to the Hematology-Cellular Therapy Service, including those undergoing CAR T-cell therapy and Allogeneic stem cell transplant. Manage acute treatment-related toxicities such as cytokine release
-
admitted to the Hematology-Cellular Therapy Service, including those undergoing CAR T-cell therapy and Allogeneic stem cell transplant. Manage acute treatment-related toxicities such as cytokine release